Endocrinology, Vol 132, 1658-1664, Copyright © 1993 by Endocrine Society

ARTICLES

Regulation of parathyroid hormone-related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500

B Liu, D Goltzman and SA Rabbani
Department of Medicine, McGill University, Montreal, Quebec, Canada.

The transplantable rat Leydig cell tumor H-500 is known to cause hypercalcemia in vivo by the release of abundant PTH-related peptide (PTHRP) and to closely reproduce the human syndrome of malignancy- associated hypercalcemia. In the rat only a single messenger RNA species of 1.4 kilobases is expressed which encodes a peptide of 141 amino acid as the sole molecular form. We have examined in cultured rat Leydig tumor cells H-500, the capacity of multiple factors to regulate PTHRP messenger RNA expression and secretion. Both fetal bovine serum and epidermal growth factor stimulated PTHRP gene expression and secretion into conditioned culture medium. Dexamethasone and 1,25- dihydroxyvitamin D3 produced inhibition of PTHRP gene expression and secretion. Furthermore, in these testicular cells, after 12 h or more of incubation, testosterone produced a dose-dependent (10(-9)-10(-7) M) inhibition of PTHRP production. No significant difference in this inhibitory response was seen between testosterone and its 5 alpha- reduced metabolite dihydrotestosterone whereas 17 beta-estradiol, progesterone, LH, FSH, and PRL were ineffective. An androgen receptor antagonist Win 49596 blocked the androgen-mediated inhibition of PTHRP gene expression and secretion, but not that due to dexamethasone. Epidermal growth factor caused an increase, whereas androgen caused a decrease in PTHRP gene transcription. These studies demonstrated that growth factors, dexamethasone, and 1,25-dihydroxyvitamin D3 are broadly active regulatory agents of PTHRP production which cross species and tissue barriers. Testosterone may be a more selective modulator which can regulate PTHRP in tissues such as Leydig cell neoplasms which express the androgen receptor.

This article has been cited by other articles:

				N. Chattopadhyay Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E761 - E770. [Abstract] [Full Text] [PDF]

				S. A. Rabbani, P. Khalili, A. Arakelian, H. Pizzi, G. Chen, and D. Goltzman Regulation of Parathyroid Hormone-Related Peptide by Estradiol: Effect on Tumor Growth and Metastasis in Vitro and in Vivo Endocrinology, July 1, 2005; 146(7): 2885 - 2894. [Abstract] [Full Text] [PDF]

				T. J. M. Moss, I. Nitsos, R. Harding, and J. P. Newnham Differential Effects of Maternal and Fetal Betamethasone Injections in Late-Gestation Fetal Sheep Reproductive Sciences, December 1, 2003; 10(8): 474 - 479. [Abstract] [PDF]

				H. Pizzi, J. Gladu, L. Carpio, D. Miao, D. Goltzman, and S. A. Rabbani Androgen Regulation of Parathyroid Hormone-Related Peptide Production in Human Prostate Cancer Cells Endocrinology, March 1, 2003; 144(3): 858 - 867. [Abstract] [Full Text] [PDF]

				F. Aklilu, J. Gladu, D. Goltzman, and S. A. Rabbani Role of Mitogen-activated Protein Kinases in the Induction of Parathyroid Hormone-related Peptide Cancer Res., March 1, 2000; 60(6): 1753 - 1760. [Abstract] [Full Text]

				K. Meerovitch, S. Wing, and D. Goltzman Proparathyroid Hormone-related Protein Is Associated with the Chaperone Protein BiP and Undergoes Proteasome-mediated Degradation J. Biol. Chem., August 14, 1998; 273(33): 21025 - 21030. [Abstract] [Full Text] [PDF]